F. Hoffmann-La Roche AG is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange.

Research Grants 165 show all


$63.3M
2015

$79.2M
2016

$70.1M
2017

$157.4M
2018

$32M
2019

Publications 777 show all

  • 25
    Escherichia coli/genetics
  • 24
    Proto-Oncogene Proteins/genetics
  • 24
    Transcription, Genetic
  • 23
    Escherichia coli Proteins
  • 21
    Carrier Proteins/metabolism
  • 21
    DNA Replication
  • 19
    Genes
  • 18
    Calcium/metabolism
  • 18
    DNA-Binding Proteins/genetics
  • 18
    Gene Expression Regulation

Patents 99,456show all

  • 20,362
    C07D - Heterocyclic compounds
  • 9,173
    A61K - Preparations for medical, dental, or toilet purposes
  • 7,956
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 7,932
    C07C - Acyclic or carbocyclic compounds
  • 5,027
    C07K - Peptides
  • 3,677
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 2,600
    C12N - Microorganisms or enzymes
  • 2,480
    A61B - Diagnosis
  • 2,076
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 1,611
    Y02P - Climate change mitigation technologies in the production or processing of goods

Clinical Trials 5,493show all

1,825Phase 31,302N/A931Phase 2512Phase 1326Phase 4192Other

Contact Information

Konzern-Hauptsitz Grenzacherstrasse 124
Basel 4070
Switzerland

Overview

Total FundingEmployeesLast Funding DateStatus
$2,790,000,00010000+2001-05-08Ipo